Lee Sung bought TNGX
April 29, 2026 · Form 4 insider transaction
Lee Sung bought 5,200 shares of Tango Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,200
Price
$0.00
Total value
N/A
InsiderLee Sung
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 29, 2026
Filing dateMay 1, 2026
Shares owned after5,200
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option shall vest and become exercisable in 36 substantially equal monthly installments over a period of three years commencing on January 2, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. The options were granted in connection with the Reporting Person's service on the Issuer's board of directors and reflect the value the Reporting Person is entitled to pursuant to the Issuer's Non-Employee Director Compensation Policy.